L V Ivanova Selected Research

DNA Topoisomerases

1/2003	[Clinical implications of DNA-topoisomerases examination in renal biopsies from patients with nephritis].
11/2001	Correlation between the expression of DNA topoisomerases I and IIalpha and clinical parameters in kidney disease.
10/2000	Expression of DNA topoisomerases in chronic proliferative kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L V Ivanova Research Topics

Disease

4	Glomerulonephritis 01/2003 - 10/2000
3	Infections 01/2016 - 11/2005
3	Sclerosis 01/2003 - 11/2001
2	Nephritis 01/2003 - 01/2002
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2002 - 11/2001
2	Proteinuria 01/2002 - 11/2001
2	Membranous Glomerulonephritis (Membranous Nephropathy) 11/2001 - 10/2000
2	Kidney Diseases (Kidney Disease) 11/2001 - 10/2000
2	Lupus Nephritis 11/2001 - 10/2000
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 11/2001 - 10/2000
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2015
1	Carcinoma (Carcinomatosis) 01/2013
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2002
1	Hematuria 01/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2002
1	Disease Progression 01/2002
1	Tics (Tic) 01/2002
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 11/2001
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2000
1	Chronic Renal Insufficiency 10/2000
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2000
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 10/2000

Drug/Important Bio-Agent (IBA)

3	DNA TopoisomerasesIBA 01/2003 - 10/2000
2	Indicators and Reagents (Reagents)IBA 01/2016 - 01/2003
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 11/2005
2	EnzymesIBA 01/2003 - 11/2001
2	CreatinineIBA 01/2002 - 11/2001
2	TinIBA 11/2001 - 10/2000
1	Lactose FDA LinkGeneric 01/2016
1	S- (1,2,3,4,4- pentachloro- 1,3- butadienyl)glutathione (GPCB)IBA 01/2016
1	VaccinesIBA 06/2015
1	Biological ProductsIBA 01/2013
1	CopperIBA 01/2013
1	Disinfectants (Biocides)IBA 01/2013
1	SilverIBA 01/2013
1	AluminumIBA 01/2013
1	Drinking WaterIBA 03/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2002
1	Immunoglobulin A (IgA)IBA 01/2002
1	Cytostatic AgentsIBA 01/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2002
1	compound 21IBA 11/2001
1	Monoclonal AntibodiesIBA 11/2001
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2000
1	trans-crotonin (CTN)IBA 10/2000
1	AutoantibodiesIBA 10/2000

Therapy/Procedure

2	Therapeutics 01/2003 - 01/2002